Bacteriophage Market
Market Insights on Bacteriophage covering sales outlook, demand forecast & up-to-date key trends
Bacteriophage Market By Product (Phage Probiotics, Phage Therapeutics), Route of Administration (Oral, Topical), Application (Gastroenterology, Respiratory Infections Treatment, Skin Infection Treatment, Wound Prophylaxis, Urogenital Infection Treatment) & Region - Forecast 2021 - 2031
Bacteriophage Market Outlook (2021-2031)
[266 Pages Report] The global demand for bacteriophage market is expected to witness significant growth at 4.2% CAGR from 2021 to 2031, topping a valuation of US$ 41.46 Mn in 2021. According to the study, the oral route of administration segment held a substantial share of around 97% in 2021 within the global market.
Market Outlook:
|
Data Points |
Market Insights |
|
Bacteriophage Market Value 2020 |
US$ 39.85 Mn |
|
Bacteriophage Market Value 2021 |
US$ 41.46 Mn |
|
Bacteriophage Market Value 2031 |
US$ 62.72 Mn |
|
CAGR 2021-2031 |
4.2% |
|
Bacteriophage Market Share of Top 5 Countries |
55.8% |
Bacteriophages are used as a dietary supplement as they are known to reduce the risk of incidence of food born infections by Escherichia, Salmonella and other gut pathogens. These dietary supplements contain a specific combination of bacteriophages which attacks particular organisms in the gut.
Phage therapeutics can be used for treatment and prevention of antibiotic resistance infections, urinary tract infections, dysentery and others. On account of these factors, the bacteriophage market is expected to grow at a significant rate over the forecast period. As per the study, bacteriophage market held nearly 1.2% of the global probiotic supplement market which was valued at US$ 34 Bn in 2021.
Let us know your requirement to get
100% FREE customization
Bacteriophage Market Analysis From 2016 To 2020 Vs Outlook For 2021 To 2031
According to Future Market Insights, the overall bacteriophage sales were valued at around US$ 41.46 Mn in 2021. The market is projected to register 4.2% CAGR and top a valuation of US 67.72 Mn by the end of 2031.
Human gut is easily prone to attack by bacteriophages. As bacteriophages are bacteria eaters, they can easily affect gut microbiota population and in-turn influence gene expression patterns in microbes.
Hence, consumption of phage probiotics promotes growth of good bacteria over bad bacteria and maintain good balance and promotes healthy lifestyle among individuals. For instance, In June 2021, Life Extension launched new formula for supporting bowel regularity, FLORASSIST® Daily Bowel Regularity.
The formula contains clinically-studied Bifidobacterium lactis HN019, a probiotic strain shown to maintain bowel regularity and also defends against occasional constipation. A slew of such developments by key players is expected to boost the market.
Rising prevalence of antibiotic resistance and limited discoveries for new antibiotics is one of the major factor propelling the growth in the market. Phages are known as super bug, as they multiply at the site of action to support healthy immune function.
This has shifted the focus of healthcare professionals in developed countries towards research and development. This is projected to improve the demand in the bacteriophage market replacing the traditional probiotics.
For instance, in January 2020, Life Extension developed a novel approach for supporting healthy liver, FLORASSIST® Liver Restore™. This is a daily, synbiotic proprietary blend that combines clinically-studied PRO-biotic bacteria with PRE-biotic that helps those strains thrive in the gut.
By route of administration, oral route segment dominated the global market in 2021, contributing about 97% of the revenue share. The trend is likely to continue in future due to its ability to prevent plaque, decrease in inflammation of gums.
As per FMI, the global bacteriophage market is expected to be valued at US$ 67.72 Mn by the end of 2031 and is projected to register a CAGR of 4.2% in the forecast period.
What Are The Key Opportunities For Bacteriophage Manufacturers?
Growing emphasis on research and development of drugs and therapies for infectious diseases is expected to create immense growth opportunities in the market. Rising interest in development of drugs for applications such as infectious diseases and immunological disorders will further boost the market.
For instance, in June 2020, Microgen opened a Biological Research Centre for study of bacteriophages. The main purpose of this centre will be to improve treatment-and-prevention drugs being an alternative to antibiotics.
According to the World Health Organization, antibiotic-resistant infections could kill about 10 million people per year by 2050. There is a huge, unmet need in patients with bacterial infections, which are mostly very difficult to treat with traditional antibiotic therapy.
Furthermore, increasing antibiotic resistance pathogen needs to be treated with bacteriophage. Rising prevalence of antibiotic resistance has surged the demand for phage therapy. For instance, In October 2021, Intralytix, Inc. received clearance from the U.S. Food and Drug Administration (FDA) for an Investigational New Drug (IND) application for its product ShigActive™.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat Are The Factors Restraining The Demand For Bacteriophage?
High cost of bacteriophage treatment is the major factor limiting the sales in the market. Due to the high cost of therapy, several healthcare facilities such as small hospitals & clinics in underdeveloped regions are not able to afford the treatment, restraining growth.
Low- to middle-income countries generate more revenue from antibiotics as compared to bacteriophage as they are cheaper and show immediate results. This is the major restraining factor for the market.
Country-Wise Insights
Why is the U.S. Considered to be the Most Lucrative Market for Bacteriophage?
“Rising Prevalence of Antibiotic Resistance to Fuel Bacteriophage Sales”
As per the study, the U.S. is expected to dominate North America bacteriophage market, accounting for a total market share of over 90% in 2021.
Growth in the market is driven by rising prevalence of antibiotic resistance and increasing demand for an alternative to antibiotics in the country.
How Big is the Opportunity for Bacteriophage Market in Russia?
“Fast Track Approval for Bacteriophage Formulations to Boost the Market
Russia is set to exhibit a CAGR of 5.8% in Europe bacteriophage market during the forecast period. Increase in research & development activities and technological advancements will promote the growth in the market.
Another factor driving the growth of this market in Russia is favourable regulatory policies and less stringent rules for approval of bacteriophage formulations as compared to USFDA.
Why is Demand for Bacteriophage Increasing in Australia?
“Australia to Emerge as the Most Lucrative Bacteriophage Market in Oceania”
Sales of bacteriophage in Australia are projected to increase at a CAGR rate of 5.2% during the forecast period. Growth of the bacteriophage market in the country is attributed to the rising wave of advancements in phage therapy strategies in the region of Oceania.
What is the Demand Outlook for Bacteriophage in India?
“India Bacteriophage Market to Spearhead the Growth in South Asia”
India accounted for about 29% of market share in 2021 and is projected to increase with a CAGR of 5.6% during the forecast period. Demand for bacteriophage is witnessing a rapid increase in antibacterial resistant infections in India.
Key companies in India are collaborating and extending their partnerships with pre-existing giants to expand their product portfolio. This is expected to facilitate the growth in the market.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Category-Wise Insights
Which Product Type is the Most Preferred?
“Phage Probiotics to Account for More than 9 out of 10 Bacteriophage Sales”
In terms of product, the phage probiotics segment accounted for about 95.5% of market share in 2021 and is expected to register a CAGR of 4.2% in the forecast period. The growth of this product is associated with its ability of improving gut flora diversity and promoting growth of good bacteria.
Which Route of Administration will Hold Significant Share in Bacteriophage Market?
“Preference for Non-Invasive Treatment to Increase the Demand for Oral Route of Administration in Bacteriophage Market”
Oral route of administration benefits the most as they have more than 96% share in revenue and is expected to grow at a CAGR of 4.3% in the forecast period. This is the most preferred route of administration since it is self-administrable, non- invasive and cost effective as well.
Which is the Chief Application in Bacteriophage Market?
“Demand for Bacteriophage Formulations in Gastroenterology to Increase”
In terms of application, sales of bacteriophage in gastroenterology reached a valuation of US$ 37.35 Mn in 2021 and is expected to increase at a CAGR of 4.3% in the forecast period. Bacteriophages are used as dietary supplements to improve gut health. Bacteriophages are still not approved by USFDA as a treatment option for many antibiotic-resistant infections in many regions.
Which Distribution Channel is Highly Sought-After in Bacteriophage Market?
“Sales of Bacteriophage to Surge through Retail Pharmacies”
Based on distribution channel, retail pharmacies segment will register a CAGR of 3.7% in the forecast period. Retail pharmacies offer various advantages such as better access to generic as well as competitive drugs, lower unit costs and assure quality customer service.
Competitive Landscape
Leading bacteriophage manufacturers are focusing on geographical expansion to increase their revenue & expand their footprint in emerging countries by acquisition of local market players.
Strategic collaborations, acquisitions, expansion, product launches, agreements and research sponsorship are the key strategies adopted by manufacturers to increase the product sales in different geographies.
For instance,
- In August 2021, Carillon Miami Wellness Resort partnered with the biostation to launch a new functional medicine practice located at the resort’s award-winning, 70,000-square-foot spa and wellness facility.
- In November 2021 Intralytix and AB Agri partnered to explore the use of bacteriophages in animal feed as an alternative to antibiotics and other drugs.
- In June 2021, BioChimpharm expanded its production capacity with the support of European union and FAO to develop an alternative to antibiotics.
Scope Of Report
|
Attribute |
Details |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
|
Market Analysis |
US$ Mn for Value |
|
Key Regions Covered |
North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa |
|
Key Countries Covered |
US, Canada, Brazil, Mexico, Argentina, Germany, U.K., France, Italy, Spain, Russia, Poland, Georgia China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, GCC Countries, Turkey and South Africa |
|
Key Market Segments Covered |
Product, Route of administration, Application, Distribution channel and Region |
|
Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Key Market Segments Covered In Bacteriophage Industry Research
By Product:
- Phage Probiotics
- Phage Therapeutics
By Route of Administration:
- Oral
- Topical
- Other
By Application:
- Gastroeneterology
- Respiratory infections market
- Skin infection treatment
- Wound prophylaxis
- Urogenital infection treatment
- Others
By Distribution Channel:
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Frequently Asked Questions
The global bacteriophage market valued US$ 41.46 Mn in 2021 and is set to expand 1.5X over the next ten years.
The bacteriophage market is expected to reach US$ 67.72 Mn by end of 2031 at a CAGR of 4.2%
Growth in the market is underpinned by rising demand for phage probiotics, better alternative for antibiotics, strategic investment by manufacturers for development of phage therapeutics.
Europe is expected to lead the market, accounting for a market share of about 42% by value in 2021 in the global bacteriophage market.
Growing inclination towards preventive healthcare in conjunction with the development of efficient combination phase therapies and expansion of product pipeline are some of the important opportunities for growth in this market.
The U.S., Poland, Russia, Australia and Georgia are the top five countries which are expected to drive demand in bacteriophage market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion & Exclusion
3. Key Market Trends
3.1. Key Trends Impacting The Market
3.2. Innovation / Development Trends
4. Market Background
4.1. Macro-Economic Factors
4.1.1. Global GDP Growth Outlook
4.1.2. Global Healthcare Expenditure Outlook
4.1.3. Regional Healthcare Market Outlook
4.2. Forecast Factors - Relevance & Impact
4.2.1. Rising focus on Research and Development
4.2.2. Rising prevalence of antimicrobial-resistance infection
4.2.3. Increasing Use of Antibiotics
4.2.4. Wide Range of Indication of Bacteriophage
4.2.5. Rising Use of Bacteriophage as Vaccine Vehicles
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity Analysis
5. COVID19 Crisis Analysis
5.1. Current COVID19 Statistics and Probable Future Impact
5.2. Current GDP Projection and Probable Impact
5.3. Current Economic Projection as compared to 2008 Economic analysis
5.4. COVID19 and Impact Analysis
5.4.1. By Product
5.4.2. By Route of Administration
5.4.3. By Application
5.4.4. By Distribution Channel
5.4.5. By Country
6. Key Success Factors
6.1. Antibiotics vs. Bacteriophage Therapy
6.2. Disease Epidemiology
6.3. Regulatory Scenario
6.4. Pipeline Analysis
6.5. Key Strategies by Manufacturers
6.6. PESTEL Analysis
6.7. PORTAL Analysis
7. Global Bacteriophage Market Demand (in Value or Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
7.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Bacteriophage Market Analysis 2016-2020 and Forecast 2021-2031, by Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis by Product, 2016-2020
8.3. Current and Future Market Size (US$ Mn) and Forecast by Product, 2021-2031
8.3.1. Phage Probiotics
8.3.2. Phage Therapeutics
8.4. Market Attractiveness Analysis by Product
9. Global Bacteriophage Market Analysis 2016-2020 and Forecast 2021-2031, by Route of Administration
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis by Usage, 2016-2020
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Route of Administration, 2021-2031
9.3.1. Oral
9.3.2. Topical
9.3.3. Others
9.4. Market Attractiveness Analysis by Route of Administration
10. Global Bacteriophage Market Analysis 2016-2020 and Forecast 2021-2031, by Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis by Application, 2016-2020
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Application, 2021-2031
10.3.1. Gastroenterology
10.3.2. Respiratory infections treatment
10.3.3. Skin infection treatment
10.3.4. Wound prophylaxis
10.3.5. Urogenital infection treatment
10.3.6. Others
10.4. Market Attractiveness Analysis by Application
11. Global Bacteriophage Market Analysis 2016-2020 and Forecast 2021-2031, by Distribution Channel
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2016-2020
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Distribution Channel, 2021-2031
11.3.1. Retail Pharmacies
11.3.2. Hospital Pharmacies
11.3.3. Online Pharmacies
11.4. Market Attractiveness Analysis by Distribution Channel
12. Global Bacteriophage Market Analysis 2016-2020 and Forecast 2021-2031, by Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis by Region, 2016-2020
12.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2021-2031
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Middle East and Africa (MEA)
12.3.5. South Asia
12.3.6. East Asia
12.3.7. Oceania
12.4. Market Attractiveness Analysis by Region
13. North America Bacteriophage Market Analysis 2016-2020 and Forecast 2021-2031
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020
13.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021-2031
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Product
13.3.3. By Route of Administration
13.3.4. By Application
13.3.5. By Distribution Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Distribution Channel
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. Latin America Bacteriophage Market 2016-2020 and Forecast 2021-2031
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020
14.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021-2031
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Product
14.3.3. By Route of Administration
14.3.4. By Application
14.3.5. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Distribution Channel
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. Europe Bacteriophage Market 2016-2020 and Forecast 2021-2031
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020
15.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021-2031
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. Poland
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Product
15.3.3. By Route of Administration
15.3.4. By Application
15.3.5. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Route of Administration
15.4.4. By Application
15.4.5. By Distribution Channel
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. South Asia Bacteriophage Market 2016-2020 and Forecast 2021-2031
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020
16.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021-2031
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Thailand
16.3.1.3. Indonesia
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Product
16.3.3. By Route of Administration
16.3.4. By Application
16.3.5. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Distribution Channel
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. East Asia Bacteriophage Market 2016-2020 and Forecast 2021-2031
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020
17.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021-2031
17.4.1. By Country
17.4.1.1. China
17.4.1.2. Japan
17.4.1.3. South Korea
17.4.2. By Product
17.4.3. By Route of Administration
17.4.4. By Application
17.4.5. By Distribution Channel
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Distribution Channel
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
18. Oceania Bacteriophage Market 2016-2020 and Forecast 2021-2031
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020
18.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021-2031
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product
18.3.3. By Route of Administration
18.3.4. By Application
18.3.5. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Distribution Channel
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. Middle East and Africa Bacteriophage Market 2016-2020 and Forecast 2021-2031
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020
19.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021-2031
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. South Africa
19.3.1.3. Turkey
19.3.1.4. Rest of Middle East and Africa
19.3.2. By Product
19.3.3. By Route of Administration
19.3.4. By Application
19.3.5. By Distribution Channel
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Distribution Channel
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
20. Country Level Bacteriophage Market Analysis 2021 & 2031
20.1. Introduction
20.1.1. Market Value Proportion Analysis
20.1.2. Global VS. Country Growth Comparison
20.2. U.S. Bacteriophage Market Analysis
20.2.1. By Distribution Channel
20.3. Canada Bacteriophage Market Analysis
20.3.1. By Distribution Channel
20.4. Mexico Bacteriophage Market Analysis
20.4.1. By Distribution Channel
20.5. Brazil Bacteriophage Market Analysis
20.5.1. By Distribution Channel
20.6. Argentina Bacteriophage Market Analysis
20.6.1. By Distribution Channel
20.7. U.K Bacteriophage Market Analysis
20.7.1. By Distribution Channel
20.8. Germany Bacteriophage Market Analysis
20.8.1. By Distribution Channel
20.9. Italy Bacteriophage Market Analysis
20.9.1. By Distribution Channel
20.10. France Bacteriophage Market Analysis
20.10.1. By Distribution Channel
20.11. Poland Bacteriophage Market Analysis
20.11.1. By Product
20.11.2. By Route of Administration
20.11.3. By Application
20.11.4. By Distribution Channel
20.12. Spain Bacteriophage Market Analysis
20.12.1. By Distribution Channel
20.13. Georgia Bacteriophage Market Analysis
20.13.1. By Product
20.13.2. By Route of Administration
20.13.3. By Application
20.13.4. By Distribution Channel
20.14. Russia Bacteriophage Market Analysis
20.14.1. By Product
20.14.2. By Route of Administration
20.14.3. By Application
20.14.4. By Distribution Channel
20.15. China Bacteriophage Market Analysis
20.15.1. By Distribution Channel
20.16. Japan Bacteriophage Market Analysis
20.16.1. By Distribution Channel
20.17. South Korea Bacteriophage Market Analysis
20.17.1. By Distribution Channel
20.18. India Bacteriophage Market Analysis
20.18.1. By Distribution Channel
20.19. Thailand Bacteriophage Market Analysis
20.19.1. By Distribution Channel
20.20. Malaysia Bacteriophage Market Analysis
20.20.1. By Distribution Channel
20.21. Indonesia Bacteriophage Market Analysis
20.21.1. By Distribution Channel
20.22. Australia Bacteriophage Market Analysis
20.22.1. By Distribution Channel
20.23. New Zealand Bacteriophage Market Analysis
20.23.1. By Distribution Channel
20.24. Turkey Bacteriophage Market Analysis
20.24.1. By Distribution Channel
20.25. GCC Countries Bacteriophage Market Analysis
20.25.1. By Distribution Channel
20.26. North Africa Bacteriophage Market Analysis
20.26.1. By Distribution Channel
20.27. South Africa Bacteriophage Market Analysis
20.27.1. By Distribution Channel
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
21.3.1. By Regional footprint of players
21.3.2. Product footprint of players
21.3.3. Channel footprint of players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Life Extension
22.3.1.1. Overview & Key Financials
22.3.1.2. Product Portfolio
22.3.1.3. Sales Footprint
22.3.1.4. SWOT Analysis
22.3.1.5. Strategy
22.3.1.5.1. Marketing Strategy
22.3.1.5.2. Product Strategy
22.3.1.5.3. Channel Strategy
22.3.2. Arthur Andrew Medical
22.3.2.1. Overview & Key Financials
22.3.2.2. Product Portfolio
22.3.2.3. Sales Footprint
22.3.2.4. SWOT Analysis
22.3.2.5. Strategy
22.3.2.5.1. Marketing Strategy
22.3.2.5.2. Product Strategy
22.3.2.5.3. Channel Strategy
22.3.3. Deerland Probiotics & Enzymes Inc.
22.3.3.1. Overview & Key Financials
22.3.3.2. Product Portfolio
22.3.3.3. Sales Footprint
22.3.3.4. SWOT Analysis
22.3.3.5. Strategy
22.3.3.5.1. Marketing Strategy
22.3.3.5.2. Product Strategy
22.3.3.5.3. Channel Strategy
22.3.4. BioChimpharm
22.3.4.1. Overview & Key Financials
22.3.4.2. Product Portfolio
22.3.4.3. Sales Footprint
22.3.4.4. SWOT Analysis
22.3.4.5. Strategy
22.3.4.5.1. Marketing Strategy
22.3.4.5.2. Product Strategy
22.3.4.5.3. Channel Strategy
22.3.5. Micreos Human Health
22.3.5.1. Overview & Key Financials
22.3.5.2. Product Portfolio
22.3.5.3. Sales Footprint
22.3.5.4. SWOT Analysis
22.3.5.5. Strategy
22.3.5.5.1. Marketing Strategy
22.3.5.5.2. Product Strategy
22.3.5.5.3. Channel Strategy
22.3.6. Designs for Health
22.3.6.1. Overview & Key Financials
22.3.6.2. Product Portfolio
22.3.6.3. Sales Footprint
22.3.6.4. SWOT Analysis
22.3.6.5. Strategy
22.3.6.5.1. Marketing Strategy
22.3.6.5.2. Product Strategy
22.3.6.5.3. Channel Strategy
22.3.7. Accelerated Health Systems llc
22.3.7.1. Overview & Key Financials
22.3.7.2. Product Portfolio
22.3.7.3. Sales Footprint
22.3.7.4. SWOT Analysis
22.3.7.5. Strategy
22.3.7.5.1. Marketing Strategy
22.3.7.5.2. Product Strategy
22.3.7.5.3. Channel Strategy
22.3.8. The biostation
22.3.8.1. Overview & Key Financials
22.3.8.2. Product Portfolio
22.3.8.3. Sales Footprint
22.3.8.4. SWOT Analysis
22.3.8.5. Strategy
22.3.8.5.1. Marketing Strategy
22.3.8.5.2. Product Strategy
22.3.8.5.3. Channel Strategy
22.3.9. Probiotic America
22.3.9.1. Overview & Key Financials
22.3.9.2. Product Portfolio
22.3.9.3. Sales Footprint
22.3.9.4. SWOT Analysis
22.3.9.5. Strategy
22.3.9.5.1. Marketing Strategy
22.3.9.5.2. Product Strategy
22.3.9.5.3. Channel Strategy
22.3.10. Microgen
22.3.10.1. Overview & Key Financials
22.3.10.2. Product Portfolio
22.3.10.3. Sales Footprint
22.3.10.4. SWOT Analysis
22.3.10.5. Strategy
22.3.10.5.1. Marketing Strategy
22.3.10.5.2. Product Strategy
22.3.10.5.3. Channel Strategy
22.3.11. IntraLytix Inc.
22.3.11.1. Overview & Key Financials
22.3.11.2. Product Portfolio
22.3.11.3. Sales Footprint
22.3.11.4. SWOT Analysis
22.3.11.5. Strategy
22.3.11.5.1. Marketing Strategy
22.3.11.5.2. Product Strategy
22.3.11.5.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
Let us know your requirement to get
100% FREE customization
Table 01: Global Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 02: Global Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Table 03: Global Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 04: Global Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 05: Global Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region
Table 06: North America Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 07: North America Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Table 08: North America Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 09: North America Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 10: North America Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 11: Latin America Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 12: Latin America Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Table 13: Latin America Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 14: Latin America Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 15: Latin America Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 16: Europe Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 17: Europe Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Table 18: Europe Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 19: Europe Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 20: Europe Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 21: South Asia Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 22: South Asia Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Table 23: South Asia Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 24: South Asia Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 25: South Asia Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 26: East Asia Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 27: East Asia Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Table 28: East Asia Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 29: East Asia Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 30: East Asia Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 31: Oceania Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 32: Oceania Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Table 33: Oceania Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 34: Oceania Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 35: Oceania Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 36: MEA Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 37: MEA Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Table 38: MEA Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 39: MEA Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 40: MEA Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystFigure 01: Global Bacteriophage Market Historical Market Value, 2016-2020
Figure 02: Global Bacteriophage Market Value (US$ Mn) & Y-o-Y Growth (%),
Figure 03:- Global Bacteriophage Market Absolute $ Opportunity, 2021 –2031
Figure 04: Global Bacteriophage Market Analysis by Product –2021 & 2031
Figure 05: Global Bacteriophage Market Y-o-Y Growth Projections by Product, 2021 – 2031
Figure 06: Global Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Figure 07: Global Bacteriophage Market Analysis by Route of Administration –2021 & 2031
Figure 08: Global Bacteriophage Market Y-o-Y Growth Projections by Route of Administration, 2021 – 2031
Figure 09: Global Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Figure 10: Global Bacteriophage Market Analysis by Application–2021 & 2031
Figure 11: Global Bacteriophage Market Y-o-Y Growth Projections by Application, 2021 – 2031
Figure 12: Global Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Figure 13: Global Bacteriophage Market Analysis by Distribution Channel –2021 & 2031
Figure 14: Global Bacteriophage Market Y-o-Y Growth Projections by Distribution Channel, 2021 – 2031
Figure 15: Global Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Figure 16: Global Bacteriophage Market Analysis by Region –2021 & 2031
Figure 17: Global Bacteriophage Market Y-o-Y Growth Projections by Region, 2021 – 2031
Figure 18: Global Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region
Figure 19: North America Bacteriophage Market Value Share, By Distribution Channel, 2021 (E)
Figure 20: North America Bacteriophage Market Value Share, By Country, 2021 (E)
Figure 21: North America Bacteriophage Market Size (US$ Mn) Analysis, 2016-2020
Figure 22: North America Bacteriophage Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 23: North America Bacteriophage Market Attractiveness Analysis by Distribution Channel, 2021–2031
Figure 24: North America Bacteriophage Market Attractiveness Analysis by Country, 2021–2031
Figure 25: Latin America Bacteriophage Market Value Share, By Distribution Channel, 2021 (E)
Figure 26: Latin America Bacteriophage Market Value Share, By Country, 2021 (E)
Figure 27: Latin America Bacteriophage Market Size (US$ Mn) Analysis, 2016-2020
Figure 28: Latin America Bacteriophage Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 29: Latin America Bacteriophage Market Attractiveness Analysis by Distribution Channel, 2021–2031
Figure 30: Latin America Bacteriophage Market Attractiveness Analysis by Country, 2021–2031
Figure 31: Europe Bacteriophage Market Value Share, By Product, 2021 (E)
Figure 32: Europe Bacteriophage Market Value Share, By Applications, 2021 (E)
Figure 33: Europe Bacteriophage Market Value Share, By Route of Administration, 2021 (E)
Figure 34: Europe Bacteriophage Market Value Share, By Distribution Channel, 2021 (E)
Figure 35: Europe Bacteriophage Market Value Share, By Country, 2021 (E)
Figure 36: Europe Bacteriophage Market Size (US$ Mn) Analysis, 2016-2020
Figure 37: Europe Bacteriophage Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 38: Europe Bacteriophage Market Attractiveness Analysis by Product, 2021–2031
Figure 39: Europe Bacteriophage Market Attractiveness Analysis by Route of Administration, 2021–2031
Figure 40: Europe Bacteriophage Market Attractiveness Analysis by Application, 2021–2031
Figure 41: Europe Bacteriophage Market Attractiveness Analysis by Distribution Channel, 2021–2031
Figure 42: Europe Bacteriophage Market Attractiveness Analysis by Country, 2021–2031
Figure 43: South Asia Bacteriophage Market Value Share, By Distribution Channel, 2021 (E)
Figure 44: South Asia Bacteriophage Market Value Share, By Country, 2021 (E)
Figure 45: South Asia Bacteriophage Market Size (US$ Mn) Analysis, 2016-2020
Figure 46: South Asia Bacteriophage Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 47: South Asia Bacteriophage Market Attractiveness Analysis by Distribution Channel, 2021–2031
Figure 48: South Asia Bacteriophage Market Attractiveness Analysis by Country, 2021–2031
Figure 49: East Asia Bacteriophage Market Value Share, By Distribution Channel, 2021 (E)
Figure 50: East Asia Bacteriophage Market Value Share, By Country, 2021 (E)
Figure 51: East Asia Bacteriophage Market Size (US$ Mn) Analysis, 2016-2020
Figure 52: East Asia Bacteriophage Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 53: East Asia Bacteriophage Market Attractiveness Analysis by Distribution Channel, 2021–2031
Figure 54: East Asia Bacteriophage Market Attractiveness Analysis by Country, 2021–2031
Figure 55: Oceania Bacteriophage Market Value Share, By Distribution Channel, 2021 (E)
Figure 56: Oceania Bacteriophage Market Value Share, By Country, 2021 (E)
Figure 57: Oceania Bacteriophage Market Size (US$ Mn) Analysis, 2016-2020
Figure 58: Oceania Bacteriophage Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 59: Oceania Bacteriophage Market Attractiveness Analysis by Distribution Channel, 2021–2031
Figure 60: Oceania Bacteriophage Market Attractiveness Analysis by Country, 2021–2031
Figure 61: MEA Bacteriophage Market Value Share, By Distribution Channel, 2021 (E)
Figure 62: MEA Bacteriophage Market Value Share, By Country, 2021 (E)
Figure 63: MEA Bacteriophage Market Size (US$ Mn) Analysis, 2016-2020
Figure 64: MEA Bacteriophage Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 65: MEA Bacteriophage Market Attractiveness Analysis by Distribution Channel, 2021–2031
Figure 66: MEA Bacteriophage Market Attractiveness Analysis by Country, 2021–2031
Figure 67: U.S. Market Value Proportion Analysis
Figure 68: U.S. Market Value Proportion Analysis
Figure 69: U.S. Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 70: Canada Market Value Proportion Analysis
Figure 71: Canada Market Value Proportion Analysis
Figure 72: Canada Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 73: Brazil Market Value Proportion Analysis
Figure 74: Brazil Market Value Proportion Analysis
Figure 75: Brazil Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 76: Mexico Market Value Proportion Analysis
Figure 77: Mexico Market Value Proportion Analysis
Figure 78: Mexico Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 79: Argentina Market Value Proportion Analysis
Figure 80: Argentina Market Value Proportion Analysis
Figure 81: Argentina Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 82: U.K Market Value Proportion Analysis
Figure 83: U.K Market Value Proportion Analysis
Figure 84: U.K Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 85: Germany Market Value Proportion Analysis
Figure 86: Germany Market Value Proportion Analysis
Figure 87: Germany Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 88: Italy Market Value Proportion Analysis
Figure 89: Italy Market Value Proportion Analysis
Figure 90: Italy Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 91: France Market Value Proportion Analysis
Figure 92: France Market Value Proportion Analysis
Figure 93: France Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 94: Poland Market Value Proportion Analysis
Figure 95: Poland Market Value Proportion Analysis
Figure 96: Poland Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 97: Poland Bacteriophage Market Share Analysis (%), By Product, 2021 & 2031
Figure 98: Poland Bacteriophage Market Share Analysis (%), By Route of Administration, 2021 & 2031
Figure 99: Poland Bacteriophage Market Share Analysis (%), By Applications, 2021 & 2031
Figure 100: Spain Market Value Proportion Analysis
Figure 101: Spain Market Value Proportion Analysis
Figure 102: Spain Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 103: Georgia Market Value Proportion Analysis
Figure 104: Georgia Market Value Proportion Analysis
Figure 105: Georgia Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 106: Georgia Bacteriophage Market Share Analysis (%), By Product, 2021 & 2031
Figure 107: Georgia Bacteriophage Market Share Analysis (%), By Route of Administration, 2021 & 2031
Figure 108: Georgia Bacteriophage Market Share Analysis (%), By Applications, 2021 & 2031
Figure 109: Russia Market Value Proportion Analysis
Figure 110: Russia Market Value Proportion Analysis
Figure 111: Russia Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 112: Russia Bacteriophage Market Share Analysis (%), By Product, 2021 & 2031
Figure 113: Russia Bacteriophage Market Share Analysis (%), By Route of Administration, 2021 & 2031
Figure 114: Russia Bacteriophage Market Share Analysis (%), By Applications, 2021 & 2031
Figure 115: China Market Value Proportion Analysis
Figure 116: China Market Value Proportion Analysis
Figure 117: China Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 118: Japan Market Value Proportion Analysis
Figure 119: Japan Market Value Proportion Analysis
Figure 120: Japan Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 121: South Korea Market Value Proportion Analysis
Figure 122: South Korea Market Value Proportion Analysis
Figure 123: South Korea Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 124: India Market Value Proportion Analysis
Figure 125: India Market Value Proportion Analysis
Figure 126: India Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 127: Thailand Market Value Proportion Analysis
Figure 128: Thailand Market Value Proportion Analysis
Figure 129: Thailand Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 130: Malaysia Market Value Proportion Analysis
Figure 131: Malaysia Market Value Proportion Analysis
Figure 132: Malaysia Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 133: Indonesia Market Value Proportion Analysis
Figure 134: Indonesia Market Value Proportion Analysis
Figure 135: Indonesia Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 136: Australia Market Value Proportion Analysis
Figure 137: Australia Market Value Proportion Analysis
Figure 138: Australia Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 139: New Zealand Market Value Proportion Analysis
Figure 140: New Zealand Market Value Proportion Analysis
Figure 141: New Zealand Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 142: Turkey Market Value Proportion Analysis
Figure 143: Turkey Market Value Proportion Analysis
Figure 144: Turkey Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 145: GCC Countries Market Value Proportion Analysis
Figure 146: GCC Countries Market Value Proportion Analysis
Figure 147: GCC Countries Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 148: North Africa Market Value Proportion Analysis
Figure 149: North Africa Market Value Proportion Analysis
Figure 150: North Africa Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 151: South Africa Market Value Proportion Analysis
Figure 152: South Africa Market Value Proportion Analysis
Figure 153: South Africa Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
